series-a
Stage
2024
Founded
1
Investors
About
Valink Therapeutics develops next-generation oncology therapeutics focusing on bispecific antibody-drug conjugates (bsADCs) to improve efficacy and safety in cancer treatment.
Explore Valink Therapuetics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.